In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

被引:133
作者
Shin, T
Yoshimura, K
Shin, T
Crafton, EB
Tsuchiya, H
Housseau, F
Koseki, H
Schulick, RD
Chen, LP
Pardoll, DM [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA
[3] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan
关键词
D O I
10.1084/jem.20050072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B7-DC, one of the recently described B7 family members, has the capacity to inhibit T cell responses via engagement of the immunoreceptor tyrosine-based inhibitory motif-containing inhibitory PD-1 receptor as well as enhance responses via an as yet unidentified costimulatory receptor. B7-DC is highly homologous to a coinhibitory B7 family member, B7-H1, which also binds PD-1. It is currently unclear which B7-DC function-costimulation or inhibition predominates in vivo. To study in vivo functions of B7-DC, we evaluated immune responses in B7-DC knockout (KO) mice. Although not eliminated, interferon-gamma (IFN-gamma) production by CD4 T cells and IFN-gamma-dependent humoral responses were reduced in B7-DC KO mice relative to wild type mice. Antigen-specific CD8 T cell responses and cytotoxic T lymphocyte (CTL) activity were also diminished in B7-DC KO mice. Hepatic tumors grew more quickly in B7-DC KO mice, associated with a decrease in intrahepatic tumor-specific CD8 T cells. These results highlight the contrasting in vivo roles of B7-DC and B7-H1 and indicate that B7-DC functions as a tuning molecule, selectively augmenting T helper 1 and CTL responses.
引用
收藏
页码:1531 / 1541
页数:11
相关论文
共 35 条
[31]   A novel transcription factor, T-bet, directs Th1 lineage commitment [J].
Szabo, SJ ;
Kim, ST ;
Costa, GL ;
Zhang, XK ;
Fathman, CG ;
Glimcher, LH .
CELL, 2000, 100 (06) :655-669
[32]   B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells [J].
Tseng, SY ;
Otsuji, M ;
Gorski, K ;
Huang, X ;
Slansky, JE ;
Pai, SI ;
Shalabi, A ;
Shin, T ;
Pardoll, DM ;
Tsuchiya, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (07) :839-845
[33]   Components of difference in HIV seropositivity rate among injection drug users between low- and high-HIV-prevalence regions [J].
Wang, JC .
AIDS AND BEHAVIOR, 2003, 7 (01) :1-8
[34]   BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 [J].
Watanabe, N ;
Gavrieli, M ;
Sedy, JR ;
Yang, JF ;
Fallarino, F ;
Loftin, SK ;
Hurchla, MA ;
Zimmerman, N ;
Sim, J ;
Zang, XX ;
Murphy, TL ;
Russell, JH ;
Allison, JP ;
Murphy, KM .
NATURE IMMUNOLOGY, 2003, 4 (07) :670-679
[35]   Estimation of the lowest triplet π,π* energy level of 1,4-tetracenequinone by use of triplet energy transfer in solution [J].
Yamaji, M ;
Takahashi, K ;
Itoh, T ;
Tobita, S .
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2002, 1 (03) :169-171